← FDA DRUG APPROVALS

FDA NDA · NDA005657

TUBOCURARINE CHLORIDE

Sponsor: BRISTOL MYERS SQUIBB

APPLICATION
NDA005657
TYPE
NDA
ORIGINAL APPROVAL
1945-02-20
LATEST ACTION
1992-11-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TUBOCURARINE CHLORIDEDiscontinued
TUBOCURARINE CHLORIDE 3MG/ML · INJECTABLE · INJECTION

Approval history

1992-11-06Manufacturing (CMC) · Supplement 10 · priorityAP
1987-06-10Labeling · Supplement 9 · priorityAP
1986-11-14Manufacturing (CMC) · Supplement 8 · priorityAP
1985-08-19Labeling · Supplement 6 · priorityAP
1985-07-22Manufacturing (CMC) · Supplement 7 · priorityAP
1980-07-28Manufacturing (CMC) · Supplement 5 · priorityAP
1980-04-29Labeling · Supplement 4 · priorityAP
1977-02-16Labeling · Supplement 3 · priorityAP
1976-12-16Labeling · Supplement 2 · priorityAP
1972-11-28Labeling · Supplement 1 · priorityAP
1945-02-20Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →